These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 30985479)

  • 41. Disappearance of R/S-methamphetamine and R/S-amphetamine from human scalp hair after discontinuation of methamphetamine abuse.
    Wang T; Shen B; Wu H; Hu J; Xu H; Shen M; Xiang P
    Forensic Sci Int; 2018 Mar; 284():153-160. PubMed ID: 29408724
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The deleterious effects of methamphetamine use on initial presentation and clinical outcomes in aneurysmal subarachnoid hemorrhage.
    Beadell NC; Thompson EM; Delashaw JB; Cetas JS
    J Neurosurg; 2012 Oct; 117(4):781-6. PubMed ID: 22920957
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Criminal justice itreatment admissions for methamphetamine use in California: a focus on Proposition 36.
    Anglin MD; Urada D; Brecht ML; Hawken A; Rawson R; Longshore D
    J Psychoactive Drugs; 2007 Nov; Suppl 4():367-81. PubMed ID: 18284103
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The association of controlling pseudoephedrine availability on methamphetamine-related emergency department visits.
    Hendrickson RG; Cloutier RL; Fu R
    Acad Emerg Med; 2010 Nov; 17(11):1216-22. PubMed ID: 21175520
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Variants in GABBR1 Gene Are Associated with Methamphetamine Dependence and Two Years' Relapse after Drug Rehabilitation.
    Zhao Y; Peng S; Jiang H; Du J; Yu S; Zhao M
    J Neuroimmune Pharmacol; 2018 Dec; 13(4):523-531. PubMed ID: 30143926
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An evaluation of the evidence that methamphetamine abuse causes cognitive decline in humans.
    Dean AC; Groman SM; Morales AM; London ED
    Neuropsychopharmacology; 2013 Jan; 38(2):259-74. PubMed ID: 22948978
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Using trauma center data to identify missed bicycle injuries and their associated costs.
    Lopez DS; Sunjaya DB; Chan S; Dobbins S; Dicker RA
    J Trauma Acute Care Surg; 2012 Dec; 73(6):1602-6. PubMed ID: 23032807
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An emerging problem: methamphetamine abuse among treatment seeking youth.
    Gonzales R; Ang A; McCann MJ; Rawson RA
    Subst Abus; 2008; 29(2):71-80. PubMed ID: 19042326
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Patterns of treatment utilization and methamphetamine use during first 10 years after methamphetamine initiation.
    Brecht ML; Lovinger K; Herbeck DM; Urada D
    J Subst Abuse Treat; 2013; 44(5):548-56. PubMed ID: 23313146
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Methamphetamine use in trauma patients: a population-based study.
    Schermer CR; Wisner DH
    J Am Coll Surg; 1999 Nov; 189(5):442-9. PubMed ID: 10549732
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of prospectively determined A118G polymorphism on treatment response to injectable naltrexone among methamphetamine-dependent patients: an open-label, pilot study.
    Pal R; Mendelson JE; Flower K; Garrison K; Yount G; Coyle JR; Galloway GP
    J Addict Med; 2015; 9(2):130-5. PubMed ID: 25622123
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Methamphetamine use among Australian workers and its implications for prevention.
    Roche AM; Pidd K; Bywood P; Freeman T
    Drug Alcohol Rev; 2008 May; 27(3):334-41. PubMed ID: 18368616
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Amphetamine-type stimulant use among men who have sex with men (MSM) in Vietnam: Results from a socio-ecological, community-based study.
    Vu NT; Holt M; Phan HT; Le HT; La LT; Tran GM; Doan TT; Nguyen TN; de Wit J
    Drug Alcohol Depend; 2016 Jan; 158():110-7. PubMed ID: 26656138
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Patterns of injury in pediatric patients in one Florida community and implications for prevention programs.
    Martin V; Langley B; Coffman S
    J Emerg Nurs; 1995 Feb; 21(1):12-6. PubMed ID: 7776569
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Orthopaedic trauma patients and depression: a prospective cohort.
    Becher S; Smith M; Ziran B
    J Orthop Trauma; 2014 Oct; 28(10):e242-6. PubMed ID: 24736695
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The prevalence of methamphetamine and amphetamine abuse in North America: a review of the indicators, 1992-2007.
    Maxwell JC; Rutkowski BA
    Drug Alcohol Rev; 2008 May; 27(3):229-35. PubMed ID: 18368603
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Escalation of methamphetamine-related crime and fatalities in the Dresden region, Germany, between 2005 and 2011.
    Pietsch J; Paulick T; Schulz K; Flössel U; Engel A; Schmitter S; Schmidt U
    Forensic Sci Int; 2013 Dec; 233(1-3):51-4. PubMed ID: 24314501
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Management of musculoskeletal injuries after the 2009 western Sumatra earthquake.
    Pang HN; Lim W; Chua WC; Seet B
    J Orthop Surg (Hong Kong); 2011 Apr; 19(1):3-7. PubMed ID: 21519067
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The epidemiology of methamphetamine use and harm in Australia.
    Degenhardt L; Roxburgh A; Black E; Bruno R; Campbell G; Kinner S; Fetherston J
    Drug Alcohol Rev; 2008 May; 27(3):243-52. PubMed ID: 18368605
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative hazards of acute myocardial infarction among hospitalized patients with methamphetamine- or cocaine-use disorders: A retrospective cohort study.
    Callaghan RC; Halliday M; Gatley J; Sykes J; Taylor L; Benny C; Kish SJ
    Drug Alcohol Depend; 2018 Jul; 188():259-265. PubMed ID: 29793190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.